Zakia BELAID-SANDAL

• See how Theranovir are developed NOV2, a monoclonal antibody targeting the Leptin-dependent NRP-1/OBR complex involved in DDR signaling and nuclear translocation

• Sharing preclinical data demonstrating NOV2’s ability to induce chromosomal instability, including centromere disruption and telomere shortening

• Exploring NOV2’s potential to overcome resistance and relapse, and its future use in combination with PARP inhibitors